Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Groen

Showing results (421-430 of 564) with videos related to

Pageof 57
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2009
[Treatment of patients with stage III non-small cell lung cancer: concurrent high-dose chemotherapy and radiotherapy]S Y El Sharouni, J G J V Aerts, S Senan, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 6, 2013
A prospective study of the effects of breastfeeding and FADS2 polymorphisms on cognition and hyperactivity/attention problemsMaria M Groen-Blokhuis, S Franić, Catharina E M van Beijsterveldt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2016
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patchesEvelyn E C de Jong, Wouter van Elmpt, Ralph T H Leijenaar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2010
Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRIAdrianus J de Langen, Vivian van den Boogaart, Mark Lubberink, et al.
Frontiers in Oncology|July 17, 2020
Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 TrialAnita J W M Brouns, Lizza E L Hendriks, Vincent van der Noort, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2003
Routine radiography does not have a role in the diagnostic evaluation of ambulatory adult febrile neutropenic cancer patientsC S M Oude Nijhuis, J A Gietema, E Vellenga, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON studyMarjolein A Heuvelmans, Joan E Walter, Robin B Peters, et al.
Oncogene|October 12, 2018
Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibitionH Rudolf de Boer, Martin Pool, Esméé Joosten, et al.
Cancer Treatment Reviews|October 5, 2023
A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatmentsFenneke Zwierenga, Bianca A M H van Veggel, Anke van den Berg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2013
A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC)H J M Groen, M A Socinski, F Grossi, et al.
Pageof 57

Showing results (421-430 of 564) with videos related to

Sort By:
Pageof 57
Nederlands Tijdschrift Voor Geneeskunde|February 6, 2009
[Treatment of patients with stage III non-small cell lung cancer: concurrent high-dose chemotherapy and radiotherapy]S Y El Sharouni, J G J V Aerts, S Senan, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 6, 2013
A prospective study of the effects of breastfeeding and FADS2 polymorphisms on cognition and hyperactivity/attention problemsMaria M Groen-Blokhuis, S Franić, Catharina E M van Beijsterveldt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2016
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patchesEvelyn E C de Jong, Wouter van Elmpt, Ralph T H Leijenaar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2010
Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRIAdrianus J de Langen, Vivian van den Boogaart, Mark Lubberink, et al.
Frontiers in Oncology|July 17, 2020
Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 TrialAnita J W M Brouns, Lizza E L Hendriks, Vincent van der Noort, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2003
Routine radiography does not have a role in the diagnostic evaluation of ambulatory adult febrile neutropenic cancer patientsC S M Oude Nijhuis, J A Gietema, E Vellenga, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON studyMarjolein A Heuvelmans, Joan E Walter, Robin B Peters, et al.
Oncogene|October 12, 2018
Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibitionH Rudolf de Boer, Martin Pool, Esméé Joosten, et al.
Cancer Treatment Reviews|October 5, 2023
A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatmentsFenneke Zwierenga, Bianca A M H van Veggel, Anke van den Berg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2013
A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC)H J M Groen, M A Socinski, F Grossi, et al.
Pageof 57